Last reviewed · How we verify

NCT04768192

Functional and MRI Evaluation of the Robot-assisted and Traditional Rehabilitation Programs on the Muscle

Status unknown Last updated 24 February 2021
What this trial tests

trial testing Physical Rehabilitation without lokomat in Traumatic Brain Injury in 20 participants. Status unknown.

Timeline
1 January 2020
Primary endpoint
30 November 2021
31 December 2021

Quick facts

Lead sponsorIRCCS Eugenio Medea
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment20
Start date1 January 2020
Primary completion30 November 2021
Estimated completion31 December 2021
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

IRCCS Eugenio Medea — full company profile →

Who can join

Adults 5 to 18, any sex, with Traumatic Brain Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Walk recovery is one of the goals of rehabilitation programs in patients with acquired brain injury. Recent experiences have shown the effectiveness of rehabilitation programs including traditional physiotherapy in combination with robotic gait training systems (Lokomat). In this context, MRI can be used to assess the treatment effects on the muscular tissue, providing useful clinical indications for the optimization of the rehabilitation programs on the basis of the damage extension and the muscle characteristics.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Traumatic Brain Injury

Currently open trials in the same condition.

Other IRCCS Eugenio Medea trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04768192.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing